Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders
Roots Analysis
MARCH 3, 2022
Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Broad Clinical Trial Landscape. Currently, nine complement therapeutics are commercially available, while around 190 molecules are under development for various disease indications. Web: [link].
52 
Let's personalize your content